Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults
Clinical trial NCT06160401 · COMPLETED
Trial details
- NCT number
- NCT06160401
- Sponsor
- Guangzhou JOYO Pharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-18
- Primary completion
- 2021-01-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.